GOLDENWELL BIOTECH, INC. Increase (Decrease) in Other Deferred Liability
GOLDENWELL BIOTECH, INC. (GWLL) reported Increase (Decrease) in Other Deferred Liability of $47.78 thousand for the 12-month period ending 2021-12-31, per its 10-K/A filed 2023-02-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherDeferredLiability · last filed 2023-02-06
- GOLDENWELL BIOTECH, INC. increase (decrease) in other deferred liability for the quarter ending 2021-12-31 was -$3.69K.
- GOLDENWELL BIOTECH, INC. increase (decrease) in other deferred liability for the quarter ending 2021-09-30 was -$5.57K.
- GOLDENWELL BIOTECH, INC. increase (decrease) in other deferred liability for the quarter ending 2021-06-30 was -$5.54K.
- GOLDENWELL BIOTECH, INC. increase (decrease) in other deferred liability for the quarter ending 2021-03-31 was $62.59K.
- GOLDENWELL BIOTECH, INC. increase (decrease) in other deferred liability for fiscal 2021 was $47.78K.
- GOLDENWELL BIOTECH, INC. increase (decrease) in other deferred liability for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Other Deferred Liability 3 month | Increase (Decrease) in Other Deferred Liability 6 month | Increase (Decrease) in Other Deferred Liability 9 month | Increase (Decrease) in Other Deferred Liability 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$3.69K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-02-06 | -$9.26K derived: sum of 2 quarters · filed 2023-02-06 | -$14.81K derived: sum of 3 quarters · filed 2023-02-06 | $47.78K 10-K/A · filed 2023-02-06 |
| 2021-09-30 | -$5.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-03 | -$11.12K derived: sum of 2 quarters · filed 2022-01-03 | $51.47K 10-Q · filed 2022-01-03 | |
| 2021-06-30 | -$5.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-02 | $57.04K 10-Q · filed 2021-12-02 | ||
| 2021-03-31 | $62.59K 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | $0.00 10-K/A · filed 2023-02-06 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-08-05 |